Immunomodulation by vitamin D in multiple sclerosis: More than IL-17

Affiliations

¹ Academic MS Center Limburg, Zuyderland Medical Center, Sittard, The Netherlands; Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. Electronic address: smolders@gmail.com.
² Academic MS Center Limburg, Zuyderland Medical Center, Sittard, The Netherlands; School For Mental Health & Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
³ Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands.

Comment

Joost Smolders et al. J Neuroimmunol. 2016.

. 2016 Mar 15:292:79-80.

doi: 10.1016/j.jneuroim.2016.01.017. Epub 2016 Jan 27.

¹ Academic MS Center Limburg, Zuyderland Medical Center, Sittard, The Netherlands; Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. Electronic address: smolders@gmail.com.
² Academic MS Center Limburg, Zuyderland Medical Center, Sittard, The Netherlands; School For Mental Health & Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
³ Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands.

No abstract available

Comment on

Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
Toghianifar N, Ashtari F, Zarkesh-Esfahani SH, Mansourian M. Toghianifar N, et al. J Neuroimmunol. 2015 Aug 15;285:125-8. doi: 10.1016/j.jneuroim.2015.05.022. Epub 2015 Jun 12. J Neuroimmunol. 2015. PMID: 26198928 Clinical Trial.